Skip to main content
. Author manuscript; available in PMC: 2015 Feb 10.
Published in final edited form as: J Control Release. 2013 Dec 8;175:1–9. doi: 10.1016/j.jconrel.2013.11.024

Figure 11.

Figure 11

Skeleton side effect evaluation analyzed by micro-CT. A: In the lumbar vertebral body, there were significant lower BMD and BV/TV in free Dex treated group when compared with all other groups (P < 0.05). B: Representative 3D images of one lumbar vertebral body from P-Dex (10 mg/kg), free Dex and control groups. It is obvious that there is less trabecular bone and trabecular connectivity in the free Dex treated group.